Delaware court rules in favor of aim immunotech and upholds board's determination that activist group's nominations are invalid

Ocala, fla.--(business wire)--aim immunotech inc. (nyse american: aim) (“aim” or the “company”) today announced the delaware court of chancery (the “court”) ruled that the nomination notice (the “notice”) submitted by a member of a group of individuals who are seeking to nominate three candidates for election to aim's four-person board of directors (the “board”) (collectively, the “activist group”) was properly rejected for being invalid under the company's bylaws. this ruling follows a trial h.
AIM Ratings Summary
AIM Quant Ranking